(MENAFN- America News Hour) Kenneth Research, in its repository of market research reports, has recently added a report titled Xerostomia (Dry Mouth) Therapeutics Market, that emphasizes on the recent market trends and opportunities available for the growth of the market for the forecast period 2022-2031. The expansion of Pruritus Therapeutics can be attributable to the rising global health expenditures as well as the quickening pace of medical innovation. The World Health Organization (WHO) reported that the average annual growth in total health spending is 6% in low- and middle-income countries and close to 4% in high-income ones. Further, in the year 2016, the expenditure made on health reached close to 10% of the GDP of the world and crossed a value of USD 7 trillion.Moreover, the median health expenditure per capita recorded in the high-income, upper-middle income, and low & lower-middle income countries, recorded to be over USD 2,000, USD 400, and USD 100 respectively. Additionally, in the same year, the spending on health in high-income countries and in the low- and middle-income countries comprised approximately 8.2% and 6.3% of the GDP respectively.
Download Sample PDF of this Report :
The market for Xerostomia (Dry Mouth) Therapeutics is anticipated to rise at a CAGR of 6% over the course of the forecast period due to rising consumer demand for high-quality healthcare services and the healthcare industry's rapid expansion. The number of people employed in the healthcare sector has grown somewhat during the last few years. The overall number of employment opportunities in the home healthcare sector in the U.S. is predicted to increase by almost 60% between the years of 2014 and 2024, according to data from the U.S. Bureau of Labor Statistics (BLS). Some of the fastest-growing occupations in the healthcare industry include occupations such as occupational therapy assistants, physical therapy assistants, home health aides, and others. In other statistics by the BLS, jobs for occupational therapy assistants between the period 2014 and 2024 is projected to hold the highest share of 43%. This is further led by physical therapy assistants, physical therapy aides, home health aides, and nurse practitioners, with a share of 41%, 39%, 38%, and 35% respectively.
The study on the Xerostomia (Dry Mouth) Therapeutics market consists of a descriptive evaluation of the overall market scope and the annual growth rate, along with the latest trends and developments in the market in terms of various parameters such as growth indicators, market segmentation, revenue, opportunities along with challenges affecting the market growth. Further, the Xerostomia (Dry Mouth) Therapeutics market is likely to attain a notable market value in 2022 as compared to the value achieved in 2031.
In Q4 2021, U.S. current-account deficit widened stood at $224.8 billion. However, in Q1 22, CAD rose by 29.6%, reached to $291.4 billion, adding $66.6 billion to the gap. Export of good and services increased by $25.7 billion to reach $1.03 trillion in the first quarter of 2022. However, country's goods and services deficit was $79.6 billion in June, down $5.3 billion from $84.9 billion in May, revised- reflecting some sight of relief. On the other hand, annual inflation rate in the country hit 8.5%. Energy CPI surged by 32.9% in July 2022, inflating the cost of logistic and signs to disrupt supply chain whilst electricity cost upsurged by 15.2%, highest since Feb 2006. Apart from that, In July 2022, existing US home sales declined 5.9% to 4.81 million (seasonally adjusted annual rate), the lowest since May of 2020 and below market expectations of 4.89 million. As mortgage rate touches highest at 6%, sales for houses declined for a sixth consecutive month. Global energy crises to remain at focal point impacting the economic activity in the U.S, pushing consumers to spend less on the products and services and save more.
On the other hand, the worst is expected to be seen in the European countries, especially during 2022 winters. The energy and gas crises has already started grappling the region, wherein many Western European countries including Germany is looking for coal fired solutions to tackle the gas supply shortage created by Russian-Ukraine conflict.
Amidst global concerns, market players have started looking for safe investments by holding on to the new technology and product launches. Factors like currency translation, disruption in global supply chain, Anti-China sentiments brewing across the globe, slowdown in Chinese economy, inflated products prices, USD getting stronger every week, decreasing purchasing power and strict measures taken by central banks/institutions across the world to ensure less spending and more saving, could hit the demand for the product and service badly in near future.
Download Sample PDF of this Report :
Healthcare Companies and Private Service Providers to have a minimal damage Caused by Inflation:
As US govt. remains committed to quality by spending more in the Medicaid and Medicare programs, incentives by govt. to medical devices, pharma companies and biotech to benefit the market players in short and long term goals. In 2021, U.S. spent $12,318/person on healthcare- highest amongst all OECD countries followed by Germany at $7,383. The federal government commitment towards healthcare systems to enable market players expanding their revenues and mitigating the risk posed by the inflation.
Market Segmentation Our in-depth analysis of the global xerostomia therapeutics market includes the following segments:
By Type
Artificial Saliva/Saliva Substitutes Salivary Stimulants
By Product
Drugs Salivary Pens Others
By Distribution Channel
Hospital Pharmacies Retail Pharmacies Drug Store Online Pharmacies
Growth Drivers and Challenges Impacting the Growth of the Global Xerostomia Therapeutics Market Growth Drivers
Increasing use of prescriptive medication Side effects of radiation therapy and chemotherapy that causes dry mouth Easy availability of medication Increasing incidence of diseases such as HIV, diabetes, and others
Challenges
Lack of awareness about the treatment among people
Key Companies Dominating the Global Xerostomia Therapeutics Market Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global xerostomia therapeutics market that are included in our report are Colgate-Palmolive Company, EUSA Pharma, GlaxoSmithKline plc, Forward Science, OraPharma (Bausch Health Companies Inc.), Parnell Pharmaceuticals, Inc., Eisai Co., Ltd., Sun Pharmaceuticals Industries Ltd., Saliwel Ltd., and Mission Pharmacal Company among others.
Download Sample PDF of this Report :
About Kenneth Research
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.
Contact Us
Kenneth Research
Email :
Phone: +1 313 462 0609